相关实验视频
Updated: Jul 14, 2026

07:33
Intralymphatic Immunotherapy and Vaccination in Mice
Published on: February 2, 2014
23.9K
过敏免疫治疗中的微针:现在和未来
Yangxue Fu1,2, Hao Chen1,2, Jin Liu1
1Department of Allergy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Current allergy and asthma reports
|October 18, 2025
概括
微针 (MNs) 为过敏原特异性免疫疗法 (AIT) 提供了一种全新的透皮方法,克服了当前方法的局限性. 这一创新策略提高了AIT的安全性,有效性和患者的坚持,以获得更好的过敏治疗结果.
科学领域:
- 过敏和免疫学 过敏和免疫学
- 皮肤病学 皮肤病学
- 纳米技术在医学中的应用
背景情况:
- 传统的过敏原特异性免疫疗法 (AIT) 方法如SCIT,SLIT和OIT面临诸多挑战,包括不良反应和患者不良坚持.
- 目前针对皮肤的AIT方法受限于过敏原透到表皮的不足.
研究的目的:
- 审查当前过敏原特异性免疫疗法 (AIT) 方法的局限性.
- 引入微针 (MNs) 作为增强AIT的跨皮平台.
主要方法:
- 对基于微针的透皮免疫疗法 (MN-TDIT) 的临床前研究的综述.
- 对MN-TDIT的过敏原传递到皮肤层和免疫反应调节的分析.
主要成果:
- 在临床前模型中,MN-TDIT有效地将过敏原输送到皮肤,增强免疫反应并减少过敏炎症.
- 与现有的AIT策略相比,MN-TDIT显示出更好的免疫性,更少的副作用和易于使用.
结论:
- 基于微针的透皮免疫疗法 (MN-TDIT) 是改善AIT安全性,疗效和患者坚持治疗的有前途的策略.
- 需要进一步研究以解决配方稳定性,优化过敏原释放,并进行MN-TDIT验证的临床试验.
相关概念视频
Allergic Reactions: Anaphylaxis
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

